-
A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times higher than the prices in 33 OECD countries. The gap was even larger for brand-name drugs.
-
The presidential election is likely to turn on the simple question of whether Americans want Donald Trump back in the White House. But health care tops the list of household financial worries for adults from both parties.
-
Suburbs in South Florida that have swung toward Donald Trump are where the Obamacare health care program is more popular than anywhere else in the country
-
The regulatory proposal was announced Nov. 15 and is likely one of the last major Obamacare policy efforts of the president’s term.
-
The president wants lawmakers to provide more funds to aid efforts to block fentanyl manufacturing and trafficking. He also says that a deal with China will require monitoring to have an impact.
-
Scholars fear that cartels will find new synthetic drugs — that may be even deadlier. Their solution: Better prevention and treatment programs.
-
The point isn’t that Donald Trump managed drug shortages badly as president or that Joe Biden is handling them badly now, experts said. Many factors contribute to the problem.
-
The initiatives include new guidance to prevent surprise medical bills and an effort to reduce medical debt tied to credit cards.
-
Health and Human Services Secretary Xavier Becerra sent a letter to governors raising concerns about large numbers of people losing coverage for administrative reasons.
-
Congress will be scrutinizing and debating the legislation, which includes provisions to fund medical care for veterans and claws back unspent COVID money.